PLIVA 709 (Propafenone Hydrochloride 225 mg)
Pill with imprint PLIVA 709 is White, Round and has been identified as Propafenone Hydrochloride 225 mg. It is supplied by Pliva Inc..
Propafenone is used in the treatment of atrial fibrillation; atrial flutter; wolff-parkinson-white syndrome; ventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PLIVA 709
Propafenone Hydrochloride
- Imprint:
- PLIVA 709
- Strength:
- 225 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Pliva Inc.
- National Drug Code (NDC):
- 50111-0709
More about propafenone
- Propafenone Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 51 Reviews
- Drug class: group I antiarrhythmics
- FDA Alerts (1)
Consumer resources
- Propafenone
- Propafenone Tablets
- Propafenone Sustained-Release Capsules
- Propafenone (Advanced Reading)
Other brands: Rythmol, Rythmol SR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
